Jim Birchenough analyst WELLS FARGO

Currently out of the existing stock ratings of Jim Birchenough, 71 are a HOLD (32.42%), 146 are a BUY (66.67%), 2 are a SELL (0.91%).

Jim Birchenough

Work Performance Price Targets & Ratings Chart

Analyst Jim Birchenough, currently employed at WELLS FARGO, carries an average stock price target met ratio of 65.2% that have a potential upside of 40.62% achieved within 450 days. Previously, Jim Birchenough worked at BMO.

Jim Birchenough’s has documented 417 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 05-Jan-2026.

Wall Street Analyst Jim Birchenough

Analyst best performing recommendations are on ARNA (ARENA PHARMACEUTICALS).
The best stock recommendation documented was for ARNA (ARENA PHARMACEUTICALS) at 12/10/2021. The price target of $71 was fulfilled within 3 days with a profit of $21.06 (42.17%) receiving and performance score of 140.57.

Average potential price target upside

AKCA Akcea Therapeutics ARNA Arena Pharmaceuticals BLCM Bellicum Pharmaceuticals BLUE Bluebird bio CRSP Crispr Therapeutics AG FATE Fate Therapeutics FPRX Five Prime Therapeutics HALO Halozyme Therapeutics ICPT Intercept Pharmaceuticals IMV IMV MRNA Moderna QURE Uniqure NV REGN Regeneron Pharmaceuticals RGLS Regulus Therapeutics SGMO Sangamo Therapeutics TCON TRACON Pharmaceuticals ZIOP ZIOPHARM Oncology ZYME Zymeworks Common Stock AMGN Amgen BIIB Biogen CELG Celgene GBT Global Blood Therapeutics GILD Gilead Sciences IMMU Immunomedics INFI Infinity Pharmaceuticals IOVA Iovance Biotherapeutics MYOK MyoKardia TCRT Alaunos Therapeutics TPTX Turning Point Therapeutics ASND Ascendis Pharma AS ARCT Arcturus Therapeutics Holdings MEIP MEI Pharma SNSS Sunesis Pharmaceuticals VIRX Viracta Therapeutics IONS Ionis Pharmaceuticals VYGR Voyager Therapeutics AGLE Aeglea Bio Therapeutics ALDR Alder BioPharmaceuticals AUTL Autolus Therapeutics Ltd JNCE Jounce Therapeutics TTPH Tetraphase Pharmaceuticals AGTC Applied Genetic AL Air Lease GBTG Global Business Travel Group KZR Kezar Life Sciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Aug-2017

$30

5 years 10 months 8 days ago
(01-Sep-2020)

2/8 (25%)

$14.76 (96.85%)

30

Hold Since 25-Sep-2018

$20

$1.83 (10.07%)

$31

6 years 2 months 3 days ago
(06-May-2020)

1/2 (50%)

$4.76 (31.23%)

9

Hold Since 07-Oct-2019

$24

6 years 9 months 2 days ago
(07-Oct-2019)

3/4 (75%)

$5.96 (33.04%)

44

Buy Since 07-Oct-2019

$45

$26.83 (147.66%)

$45

6 years 9 months 2 days ago
(07-Oct-2019)

0/2 (0%)

$25.13 (126.47%)

Hold Since 07-Aug-2018

7 years 9 months 14 days ago
(25-Sep-2018)

3/3 (100%)

$-5.99 (-15.36%)

24

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Jim Birchenough?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?